|
Market Closed -
Hong Kong S.E.
04:08:09 2026-10-02 EDT
|
5-day change | 1st Jan Change | ||
| 18.50 HKD | -1.18% |
|
-2.32% | -43.60% |
| 09-20 | VISEN Pharmaceuticals(SEHK:2561) dropped from S&P Global BMI Index | CI |
| 08-27 | VISEN Pharmaceuticals Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
Company Valuation: VISEN Pharmaceuticals
Data adjusted to current consolidation scope
| Fiscal Period: December | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| Market Cap 1 | 3,095 | 1,728 | - | - |
| Change | - | -44.19% | - | - |
| Enterprise Value (EV) 1 | 2,640 | 1,465 | 1,728 | 1,868 |
| Change | - | -44.49% | 17.93% | 8.08% |
| P/E | -12.1x | - | - | - |
| PBR | 4.22x | 3.46x | 6.96x | 16.1x |
| PEG | -0.5x | - | - | - |
| Capitalization / Revenue | 18,761x | 25.5x | 5.4x | 2.01x |
| EV / Revenue | 15,999x | 21.6x | 5.4x | 2.17x |
| EV / EBITDA | -12.1x | -6.07x | -6.59x | -11.4x |
| EV / EBIT | -12.7x | -5.96x | -6.54x | -11.2x |
| EV / FCF | - | - | - | - |
| FCF Yield | - | - | - | - |
| Dividend per Share 2 | - | - | - | - |
| Rate of return | - | - | - | - |
| EPS 2 | -2.44 | - | - | - |
| Distribution rate | - | - | - | - |
| Net sales 1 | 0.165 | 67.73 | 319.8 | 860.8 |
| EBITDA 1 | -218 | -241.4 | -262.4 | -164.1 |
| EBIT 1 | -208.6 | -245.7 | -264.3 | -166.2 |
| Net income | -253.4 | - | - | - |
| Net Debt 1 | -455.7 | -262.3 | 0.4861 | 140.2 |
| Reference price 2 | 29.47 | 15.81 | 15.81 | 15.81 |
| Nbr of stocks (in thousands) | 105,021 | 109,295 | - | - |
| Announcement Date | 3/12/26 | - | - | - |
1CNY in Million2CNY
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | 21.63x | -6.07x | -.--% | 258M | |
| 21.73x | 7.71x | 15.48x | 1.37% | 74.16B | |
| 29.82x | 8.57x | 26.7x | 0.04% | 57.39B | |
| 32.98x | 5.93x | 17.77x | 0.98% | 47.64B | |
| -21.31x | 230.81x | -22.97x | -.--% | 44.29B | |
| 33.26x | 3.23x | 13.97x | -.--% | 42.5B | |
| 46.77x | 5.41x | 29.66x | -.--% | 40.71B | |
| 27.63x | 7.93x | 20.48x | 0.41% | 30.97B | |
| 32.99x | 7.05x | 18.3x | -.--% | 28.53B | |
| -15.1x | 5.68x | -7.14x | -.--% | 24.34B | |
| Average | 20.98x | 30.39x | 10.62x | 0.28% | 39.08B | |
| Weighted average by Cap. | 22.27x | 32.03x | 13.54x | 0.42% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- 2561 Stock
- Valuation VISEN Pharmaceuticals
Select your edition
All financial news and data tailored to specific country editions
